NORPLANT SYSTEM IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Norplant System In Plastic Container patents expire, and what generic alternatives are available?
Norplant System In Plastic Container is a drug marketed by Wyeth Pharms Inc and is included in one NDA.
The generic ingredient in NORPLANT SYSTEM IN PLASTIC CONTAINER is levonorgestrel. There are twenty drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the levonorgestrel profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Norplant System In Plastic Container
A generic version of NORPLANT SYSTEM IN PLASTIC CONTAINER was approved as levonorgestrel by NOVEL LABS INC on February 22nd, 2013.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NORPLANT SYSTEM IN PLASTIC CONTAINER?
- What are the global sales for NORPLANT SYSTEM IN PLASTIC CONTAINER?
- What is Average Wholesale Price for NORPLANT SYSTEM IN PLASTIC CONTAINER?
Summary for NORPLANT SYSTEM IN PLASTIC CONTAINER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 112 |
| Clinical Trials: | 7 |
| Patent Applications: | 4,939 |
| DailyMed Link: | NORPLANT SYSTEM IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for NORPLANT SYSTEM IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Women and Infants Hospital of Rhode Island | N/A |
| Oregon Health and Science University | Phase 4 |
| Society of Family Planning | Phase 4 |
See all NORPLANT SYSTEM IN PLASTIC CONTAINER clinical trials
US Patents and Regulatory Information for NORPLANT SYSTEM IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | NORPLANT SYSTEM IN PLASTIC CONTAINER | levonorgestrel | IMPLANT;IMPLANTATION | 020088-001 | Dec 10, 1990 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NORPLANT SYSTEM IN PLASTIC CONTAINER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Wyeth Pharms Inc | NORPLANT SYSTEM IN PLASTIC CONTAINER | levonorgestrel | IMPLANT;IMPLANTATION | 020088-001 | Dec 10, 1990 | 3,850,911 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NORPLANT SYSTEM IN PLASTIC CONTAINER
See the table below for patents covering NORPLANT SYSTEM IN PLASTIC CONTAINER around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Austria | 256353 | ⤷ Start Trial | |
| Austria | 264728 | ⤷ Start Trial | |
| Austria | 264731 | ⤷ Start Trial | |
| Austria | 268544 | ⤷ Start Trial | |
| Austria | 281313 | ⤷ Start Trial | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for NORPLANT SYSTEM IN PLASTIC CONTAINER
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1453521 | 122015000093 | Germany | ⤷ Start Trial | PRODUCT NAME: LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 87675.00.00 20150720; FIRST REGISTRATION: SLOWAKEI 17/0017/15-S 20150129 |
| 1453521 | CA 2016 00016 | Denmark | ⤷ Start Trial | PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211 |
| 1453521 | 93156 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: LEVONORGESTREL ET ETHINYLESTRADIOL; FIRST REGISTRATION DATE: 20150211 |
| 1453521 | 300814 | Netherlands | ⤷ Start Trial | PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
| 1453521 | 39/2015 | Austria | ⤷ Start Trial | PRODUCT NAME: ETHINYLESTRADIOL UND EINE KOMBINATION VON LEVONORGESTREL UND ETHINYLESTRADIOL; NAT. REGISTRATION NO/DATE: 136021 20150224; FIRST REGISTRATION: SK 17/0017/15-S 20150211 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch